Granisetron Market, Global Outlook and Forecast 2022-2028

March 2022 | 105 pages | ID: GF76BDFF36DCEN
Market Monitor Global

Abstracts

Granisetron is a serotonin 5-HT3 receptor antagonist used as an antiemetic to treat nausea and vomiting following chemotherapy and Radiotherapy. Its main effect is to reduce the activity of the vagus nerve, which is a nerve that activates the vomiting center in the medulla oblongata.

This report contains market size and forecasts of Granisetron in Global, including the following market information:

Global Granisetron Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Granisetron market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Transdermal system Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Granisetron include Kyowa Kirin, Heron Therapeutics, Fresenius Kabi, Hikma Pharmaceuticals, Teva, Cipla, Sandoz, Wockhardt and Mylan, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Granisetron companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Granisetron Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Granisetron Market Segment Percentages, by Type, 2021 (%)

• Transdermal system
• Injection
• Oral

Global Granisetron Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Granisetron Market Segment Percentages, by Application, 2021 (%)

• Chemotherapy
• Post operative

Global Granisetron Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Granisetron Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Granisetron revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Granisetron revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Kyowa Kirin
• Heron Therapeutics
• Fresenius Kabi
• Hikma Pharmaceuticals
• Teva
• Cipla
• Sandoz
• Wockhardt
• Mylan
• APOTEX
• Dr.Reddy's
• Bluepharma
• Natco Pharma
• Akorn
• Taro Pharmaceutical
• Aurobindo

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Granisetron Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Granisetron Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL GRANISETRON OVERALL MARKET SIZE

2.1 Global Granisetron Market Size: 2021 VS 2028
2.2 Global Granisetron Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Granisetron Players in Global Market
3.2 Top Global Granisetron Companies Ranked by Revenue
3.3 Global Granisetron Revenue by Companies
3.4 Top 3 and Top 5 Granisetron Companies in Global Market, by Revenue in 2021
3.5 Global Companies Granisetron Product Type
3.6 Tier 1, Tier 2 and Tier 3 Granisetron Players in Global Market
  3.6.1 List of Global Tier 1 Granisetron Companies
  3.6.2 List of Global Tier 2 and Tier 3 Granisetron Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Granisetron Market Size Markets, 2021 & 2028
  4.1.2 Transdermal system
  4.1.3 Injection
  4.1.4 Oral
4.2 By Type - Global Granisetron Revenue & Forecasts
  4.2.1 By Type - Global Granisetron Revenue, 2017-2022
  4.2.2 By Type - Global Granisetron Revenue, 2023-2028
  4.2.3 By Type - Global Granisetron Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Granisetron Market Size, 2021 & 2028
  5.1.2 Chemotherapy
  5.1.3 Post operative
5.2 By Application - Global Granisetron Revenue & Forecasts
  5.2.1 By Application - Global Granisetron Revenue, 2017-2022
  5.2.2 By Application - Global Granisetron Revenue, 2023-2028
  5.2.3 By Application - Global Granisetron Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Granisetron Market Size, 2021 & 2028
6.2 By Region - Global Granisetron Revenue & Forecasts
  6.2.1 By Region - Global Granisetron Revenue, 2017-2022
  6.2.2 By Region - Global Granisetron Revenue, 2023-2028
  6.2.3 By Region - Global Granisetron Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Granisetron Revenue, 2017-2028
  6.3.2 US Granisetron Market Size, 2017-2028
  6.3.3 Canada Granisetron Market Size, 2017-2028
  6.3.4 Mexico Granisetron Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Granisetron Revenue, 2017-2028
  6.4.2 Germany Granisetron Market Size, 2017-2028
  6.4.3 France Granisetron Market Size, 2017-2028
  6.4.4 U.K. Granisetron Market Size, 2017-2028
  6.4.5 Italy Granisetron Market Size, 2017-2028
  6.4.6 Russia Granisetron Market Size, 2017-2028
  6.4.7 Nordic Countries Granisetron Market Size, 2017-2028
  6.4.8 Benelux Granisetron Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Granisetron Revenue, 2017-2028
  6.5.2 China Granisetron Market Size, 2017-2028
  6.5.3 Japan Granisetron Market Size, 2017-2028
  6.5.4 South Korea Granisetron Market Size, 2017-2028
  6.5.5 Southeast Asia Granisetron Market Size, 2017-2028
  6.5.6 India Granisetron Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Granisetron Revenue, 2017-2028
  6.6.2 Brazil Granisetron Market Size, 2017-2028
  6.6.3 Argentina Granisetron Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Granisetron Revenue, 2017-2028
  6.7.2 Turkey Granisetron Market Size, 2017-2028
  6.7.3 Israel Granisetron Market Size, 2017-2028
  6.7.4 Saudi Arabia Granisetron Market Size, 2017-2028
  6.7.5 UAE Granisetron Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Kyowa Kirin
  7.1.1 Kyowa Kirin Corporate Summary
  7.1.2 Kyowa Kirin Business Overview
  7.1.3 Kyowa Kirin Granisetron Major Product Offerings
  7.1.4 Kyowa Kirin Granisetron Revenue in Global Market (2017-2022)
  7.1.5 Kyowa Kirin Key News
7.2 Heron Therapeutics
  7.2.1 Heron Therapeutics Corporate Summary
  7.2.2 Heron Therapeutics Business Overview
  7.2.3 Heron Therapeutics Granisetron Major Product Offerings
  7.2.4 Heron Therapeutics Granisetron Revenue in Global Market (2017-2022)
  7.2.5 Heron Therapeutics Key News
7.3 Fresenius Kabi
  7.3.1 Fresenius Kabi Corporate Summary
  7.3.2 Fresenius Kabi Business Overview
  7.3.3 Fresenius Kabi Granisetron Major Product Offerings
  7.3.4 Fresenius Kabi Granisetron Revenue in Global Market (2017-2022)
  7.3.5 Fresenius Kabi Key News
7.4 Hikma Pharmaceuticals
  7.4.1 Hikma Pharmaceuticals Corporate Summary
  7.4.2 Hikma Pharmaceuticals Business Overview
  7.4.3 Hikma Pharmaceuticals Granisetron Major Product Offerings
  7.4.4 Hikma Pharmaceuticals Granisetron Revenue in Global Market (2017-2022)
  7.4.5 Hikma Pharmaceuticals Key News
7.5 Teva
  7.5.1 Teva Corporate Summary
  7.5.2 Teva Business Overview
  7.5.3 Teva Granisetron Major Product Offerings
  7.5.4 Teva Granisetron Revenue in Global Market (2017-2022)
  7.5.5 Teva Key News
7.6 Cipla
  7.6.1 Cipla Corporate Summary
  7.6.2 Cipla Business Overview
  7.6.3 Cipla Granisetron Major Product Offerings
  7.6.4 Cipla Granisetron Revenue in Global Market (2017-2022)
  7.6.5 Cipla Key News
7.7 Sandoz
  7.7.1 Sandoz Corporate Summary
  7.7.2 Sandoz Business Overview
  7.7.3 Sandoz Granisetron Major Product Offerings
  7.7.4 Sandoz Granisetron Revenue in Global Market (2017-2022)
  7.7.5 Sandoz Key News
7.8 Wockhardt
  7.8.1 Wockhardt Corporate Summary
  7.8.2 Wockhardt Business Overview
  7.8.3 Wockhardt Granisetron Major Product Offerings
  7.8.4 Wockhardt Granisetron Revenue in Global Market (2017-2022)
  7.8.5 Wockhardt Key News
7.9 Mylan
  7.9.1 Mylan Corporate Summary
  7.9.2 Mylan Business Overview
  7.9.3 Mylan Granisetron Major Product Offerings
  7.9.4 Mylan Granisetron Revenue in Global Market (2017-2022)
  7.9.5 Mylan Key News
7.10 APOTEX
  7.10.1 APOTEX Corporate Summary
  7.10.2 APOTEX Business Overview
  7.10.3 APOTEX Granisetron Major Product Offerings
  7.10.4 APOTEX Granisetron Revenue in Global Market (2017-2022)
  7.10.5 APOTEX Key News
7.11 Dr.Reddy's
  7.11.1 Dr.Reddy's Corporate Summary
  7.11.2 Dr.Reddy's Business Overview
  7.11.3 Dr.Reddy's Granisetron Major Product Offerings
  7.11.4 Dr.Reddy's Granisetron Revenue in Global Market (2017-2022)
  7.11.5 Dr.Reddy's Key News
7.12 Bluepharma
  7.12.1 Bluepharma Corporate Summary
  7.12.2 Bluepharma Business Overview
  7.12.3 Bluepharma Granisetron Major Product Offerings
  7.12.4 Bluepharma Granisetron Revenue in Global Market (2017-2022)
  7.12.5 Bluepharma Key News
7.13 Natco Pharma
  7.13.1 Natco Pharma Corporate Summary
  7.13.2 Natco Pharma Business Overview
  7.13.3 Natco Pharma Granisetron Major Product Offerings
  7.13.4 Natco Pharma Granisetron Revenue in Global Market (2017-2022)
  7.13.5 Natco Pharma Key News
7.14 Akorn
  7.14.1 Akorn Corporate Summary
  7.14.2 Akorn Business Overview
  7.14.3 Akorn Granisetron Major Product Offerings
  7.14.4 Akorn Granisetron Revenue in Global Market (2017-2022)
  7.14.5 Akorn Key News
7.15 Taro Pharmaceutical
  7.15.1 Taro Pharmaceutical Corporate Summary
  7.15.2 Taro Pharmaceutical Business Overview
  7.15.3 Taro Pharmaceutical Granisetron Major Product Offerings
  7.15.4 Taro Pharmaceutical Granisetron Revenue in Global Market (2017-2022)
  7.15.5 Taro Pharmaceutical Key News
7.16 Aurobindo
  7.16.1 Aurobindo Corporate Summary
  7.16.2 Aurobindo Business Overview
  7.16.3 Aurobindo Granisetron Major Product Offerings
  7.16.4 Aurobindo Granisetron Revenue in Global Market (2017-2022)
  7.16.5 Aurobindo Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Granisetron Market Opportunities & Trends in Global Market
Table 2. Granisetron Market Drivers in Global Market
Table 3. Granisetron Market Restraints in Global Market
Table 4. Key Players of Granisetron in Global Market
Table 5. Top Granisetron Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Granisetron Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Granisetron Revenue Share by Companies, 2017-2022
Table 8. Global Companies Granisetron Product Type
Table 9. List of Global Tier 1 Granisetron Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Granisetron Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Granisetron Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Granisetron Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Granisetron Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Granisetron Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Granisetron Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Granisetron Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Granisetron Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Granisetron Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Granisetron Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Granisetron Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Granisetron Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Granisetron Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Granisetron Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Granisetron Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Granisetron Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Granisetron Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Granisetron Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Granisetron Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Granisetron Revenue, (US$, Mn), 2023-2028
Table 30. Kyowa Kirin Corporate Summary
Table 31. Kyowa Kirin Granisetron Product Offerings
Table 32. Kyowa Kirin Granisetron Revenue (US$, Mn), (2017-2022)
Table 33. Heron Therapeutics Corporate Summary
Table 34. Heron Therapeutics Granisetron Product Offerings
Table 35. Heron Therapeutics Granisetron Revenue (US$, Mn), (2017-2022)
Table 36. Fresenius Kabi Corporate Summary
Table 37. Fresenius Kabi Granisetron Product Offerings
Table 38. Fresenius Kabi Granisetron Revenue (US$, Mn), (2017-2022)
Table 39. Hikma Pharmaceuticals Corporate Summary
Table 40. Hikma Pharmaceuticals Granisetron Product Offerings
Table 41. Hikma Pharmaceuticals Granisetron Revenue (US$, Mn), (2017-2022)
Table 42. Teva Corporate Summary
Table 43. Teva Granisetron Product Offerings
Table 44. Teva Granisetron Revenue (US$, Mn), (2017-2022)
Table 45. Cipla Corporate Summary
Table 46. Cipla Granisetron Product Offerings
Table 47. Cipla Granisetron Revenue (US$, Mn), (2017-2022)
Table 48. Sandoz Corporate Summary
Table 49. Sandoz Granisetron Product Offerings
Table 50. Sandoz Granisetron Revenue (US$, Mn), (2017-2022)
Table 51. Wockhardt Corporate Summary
Table 52. Wockhardt Granisetron Product Offerings
Table 53. Wockhardt Granisetron Revenue (US$, Mn), (2017-2022)
Table 54. Mylan Corporate Summary
Table 55. Mylan Granisetron Product Offerings
Table 56. Mylan Granisetron Revenue (US$, Mn), (2017-2022)
Table 57. APOTEX Corporate Summary
Table 58. APOTEX Granisetron Product Offerings
Table 59. APOTEX Granisetron Revenue (US$, Mn), (2017-2022)
Table 60. Dr.Reddy's Corporate Summary
Table 61. Dr.Reddy's Granisetron Product Offerings
Table 62. Dr.Reddy's Granisetron Revenue (US$, Mn), (2017-2022)
Table 63. Bluepharma Corporate Summary
Table 64. Bluepharma Granisetron Product Offerings
Table 65. Bluepharma Granisetron Revenue (US$, Mn), (2017-2022)
Table 66. Natco Pharma Corporate Summary
Table 67. Natco Pharma Granisetron Product Offerings
Table 68. Natco Pharma Granisetron Revenue (US$, Mn), (2017-2022)
Table 69. Akorn Corporate Summary
Table 70. Akorn Granisetron Product Offerings
Table 71. Akorn Granisetron Revenue (US$, Mn), (2017-2022)
Table 72. Taro Pharmaceutical Corporate Summary
Table 73. Taro Pharmaceutical Granisetron Product Offerings
Table 74. Taro Pharmaceutical Granisetron Revenue (US$, Mn), (2017-2022)
Table 75. Aurobindo Corporate Summary
Table 76. Aurobindo Granisetron Product Offerings
Table 77. Aurobindo Granisetron Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Granisetron Segment by Type in 2021
Figure 2. Granisetron Segment by Application in 2021
Figure 3. Global Granisetron Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Granisetron Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Granisetron Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Granisetron Revenue in 2021
Figure 8. By Type - Global Granisetron Revenue Market Share, 2017-2028
Figure 9. By Application - Global Granisetron Revenue Market Share, 2017-2028
Figure 10. By Region - Global Granisetron Revenue Market Share, 2017-2028
Figure 11. By Country - North America Granisetron Revenue Market Share, 2017-2028
Figure 12. US Granisetron Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Granisetron Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Granisetron Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Granisetron Revenue Market Share, 2017-2028
Figure 16. Germany Granisetron Revenue, (US$, Mn), 2017-2028
Figure 17. France Granisetron Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Granisetron Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Granisetron Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Granisetron Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Granisetron Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Granisetron Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Granisetron Revenue Market Share, 2017-2028
Figure 24. China Granisetron Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Granisetron Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Granisetron Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Granisetron Revenue, (US$, Mn), 2017-2028
Figure 28. India Granisetron Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Granisetron Revenue Market Share, 2017-2028
Figure 30. Brazil Granisetron Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Granisetron Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Granisetron Revenue Market Share, 2017-2028
Figure 33. Turkey Granisetron Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Granisetron Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Granisetron Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Granisetron Revenue, (US$, Mn), 2017-2028
Figure 37. Kyowa Kirin Granisetron Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Heron Therapeutics Granisetron Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Fresenius Kabi Granisetron Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Hikma Pharmaceuticals Granisetron Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Teva Granisetron Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Cipla Granisetron Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Sandoz Granisetron Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Wockhardt Granisetron Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Mylan Granisetron Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. APOTEX Granisetron Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Dr.Reddy's Granisetron Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Bluepharma Granisetron Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Natco Pharma Granisetron Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Akorn Granisetron Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Taro Pharmaceutical Granisetron Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Aurobindo Granisetron Revenue Year Over Year Growth (US$, Mn) & (2017-2022)